fbpx

Case №44

Neurotrofic foot ulcer

Time period for the presence of a wound : 6 months

Application of Mirragen: 20.11.19

Zhytomyr Regional Military Hospital


  • Patient:

    Men

  • Age:

    65 years old

  • Diagnosis:

    Neurotrofic foot ulcer

Dynamics of treatment with Mirragen

  • Neurotrofic foot ulcer

    At the beginning

  • Neurotrofic foot ulcer

    1 day

  • Neurotrofic foot ulcer

    7 day

Mirragen - a remedy for the treatment of trophic and chronic ulcers at different stages.

Trophic ulcers are considered the main problem with varicose veins, diabetes and long-term non-healing wounds. Mirragen can significantly shorten the healing and regeneration of tissues.

Pharmacological action Mirragen

The special structure of Mirragen promotes the growth of soft tissues in the space of the wound channel. This simulates a fibrin clot to stimulate the successive healing of vascular ulcers. The tool "captures" platelets and other components that are involved in wound healing. Borate fibers are mixed with wound exudate, in the process ions are released, which stimulate the following processes:

  • Enhanced growth of soft tissues, blood vessels;
  • Enhanced blood flow to the damaged area is provided;
  • Improves the absorption of trace elements
  • The growth of enzymes, fibroblasts is stimulated.
  • Due to these properties, the drug is successfully used in various branches of surgical interventions - orthopedics, transplantology, laser surgery.
Indications for use Mirragen

In addition to helping with chronic ulcers and wounds, Mirragen dressing is also used to heal skin and soft tissue injuries and ulcers caused by the following:

  • Infected surgical wounds.
  • Diabetic foot
  • Healing of non-globular and small-globular ulcers on the legs with varicose veins.
  • Treatment of pressure sores.
  • Regeneration of fresh wounds and surgical incisions.
  •  Healing burns of I and II degrees.
Mirragen Terms of Use

It is necessary to apply Mirragen in compliance with all the rules and requirements of asepsis and antiseptics in sterile conditions, that is, in a hospital. For effective action, the primary surgical treatment of the wound channel is preliminarily carried out, that is, the necrotic tissue is truncated, excess moisture and purulent contents are removed.

Mirragen is available as a matrix. To apply to the wound, it is necessary to cut a piece of the required size and completely close the wound channel with it. If it is necessary to treat a large wound, you can additionally use sterile gauze napkins.

During the integration of Mirragen into the open tissue of the wound, some visual changes are observed:

  • Mucus production;
  • Uniform deepening of the matrix into the thickness of soft tissues
  • Formed tissue granulation.

Sometimes the matrix is ​​displaced during the granulation process, this can reduce the effectiveness of the healing process, so it is very important to apply the dressing correctly from the beginning.

Mirragen dressing is applied daily for 3-4 days. Further, within two weeks, the regularity decreases to once every three days. Subsequently, the condition of the dressing is checked at intervals of 3-5 days and, if necessary, it is replaced.

Some redness may occur during the healing process with Mirragen Matrix. This is normal. Sometimes discoloration of the matrix occurs on contact with the wound surface. Dry skin edges can look too dry and chapped.

Removing Mirragen from a wound

Since the structure of the agent completely dissolves in the content of the wound channel, there is practically nothing to remove. If necessary, after the completion of the treatment course, the wound is washed, all remnants of Mirragen parts or fibers and gauze dressing will be washed off.